Page 295 - AIDSBK23C
P. 295
Page 295
Table 7 - Therapies for Diseases Indicative of AIDS
Disease Process Clinical Therapy
Candidiasis, oral Clotrimazole troches, topical nystatin
Candidiasis, esophageal Clotrimazole troches, topical nystatin, fluconazole, ketoconazole
Candidiasis, vulvovaginal Miconazole, clotrimazole suppositories
Cervical cancer Surgical therapy
Coccidioides immitis Amphotericin B
Cryptococcus neoformans Amphotericin B with or without flucytosine; or fluconazole or itraconazole
Cryptosporidium Paromomycin
Cytomegalovirus Ganciclovir, foscarnet
Herpes simplex or zoster Acyclovir
Histoplasma capsulatum Amphotericin B, or itraconazole, or fluconazole
Isosporiasis Trimethoprim-sulfamethoxazole
Microsporidium Albendazole (for Septata intestinalis)
Giardia lamblia Metronidazole
Kaposi's sarcoma Surgical therapy, chemotherapy, radiation therapy
LIP None effective
Malignant Lymphoma Chemotherapy, radiation therapy, surgical therapy
M tuberculosis Isoniazid, rifampin, pyrazinamide, plus ethambutol for resistance
M avium complex Rifabutin, clarithromycin, ethambutol
PML Cytosine arabinoside
P jiroveci (carinii) pneumonia Trimethoprim-sulfamethoxazole, or pentamidine, trimetrexate
Pneumonia, recurrent Antibiotic therapy appropriate to sensitivity of bacteria cultured
Salmonellosis Amoxicillin, trimethoprim-sulfamethoxazole, ciprofloxacin
Toxoplasma gondii Pyrimethamine with sulfadiazine and folinic acid
Key: LIP=lymphoid interstitial pneumonitis; PML=progressive multifocal leukoencephalopathy
